First human tests for potential HIV & COVID drug
NCT ID NCT06991634
Summary
This early-stage study aimed to understand how the body absorbs and processes Azvudine tablets in healthy adults and elderly volunteers. Researchers gave small doses to 24 participants and closely monitored drug levels in their blood and checked for any side effects. The goal was to gather basic safety and dosing information for this drug, which is being studied for HIV and COVID-19.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tianjin Fifth Central Hospital
Tianjin, Tianjin Municipality, China
Conditions
Explore the condition pages connected to this study.